Benign prostate syndrome (BPS) affects more than half of all men over the age of 50. It is often suppressed for a long time, especially because the corresponding examinations are shied away from. Therapy is varied, and many treatment options have been added in recent years that can help improve symptoms. These options advertise themselves primarily as avoiding the dreaded side effects of surgery: Incontinence, impotence and loss of ejaculation.This book provides an overview of all currently available treatment options for BPH and targeted diagnostics. Under the leadership of the renowned editors, many experts have compiled their knowledge in this practical book. Differential diagnostics with imaging and urodynamics are explained, and the many ways of therapy from watchful waiting to drug therapy to surgery are discussed and the advantages and disadvantages pointed out. A separate chapter is devoted to prevention. In addition, myths that still prevail in many places as “expert opinion” are discussed.

A practical book for every urologist!

Twenty years have passed since the last edition of the Springer textbook “Benign Prostatic Hyperplasia—A Guide for the Clinic and Practice” by the editorial team Klaus Höfner, Christian Stief & Udo Jonas.

Twenty years—two decades—represent half an eternity in science. A rough PubMed-based literature search with the search term “benign prostatic hyperplasia” and the input period 2000–2021 yielded 16,746 hits on May 18, 2021, 10 pm! But not only scientifically a lot has happened. While the editorial team was still studying (pre-clinic: C. Netsch) or looking for a chief physician position (senior physician: A. J. Gross) at that time, the reading and working habits in the medical field have also changed fundamentally in the two decades due to the triumph of the World Wide Web and social media platforms such as YouTube. Digital media are the rule in 2021 and not the exception as in 2000. Back then, downloading pdfs was still a pleasant exception for the editor (C. Netsch) when doing literature research for his dissertation. Reading microfiche and ordering articles from other libraries was more the standard than the exception.

Why publish a textbook in 2021, when search engines can find everything on the Internet (PubMed, Wikipedia) in milliseconds? The half-life of information has noticeably decreased due to an almost unmanageable number of new urological journals (with and without peer review), which all want or have to be filled with articles on a monthly basis. Journals/articles are created in monthly cycles, whose scientific value sometimes cannot be checked so quickly. These journals today compete with the institutions of then AND today, such as the Journal of Urology or the British Journal of Urology. As a result, a quick, targeted information search in the data jungle of the Internet and a multitude of duplicate publications in important and less important journals with and without impact factors (“publish by numbers”) is not easier for urologists who are not “inside” the topic than in 2000. That is why, we think, textbooks are needed! Here we see all the more the justification for a textbook, whether as a digital or paper edition: to guide the reader through the topic as up-to-date as possible (and necessary) by a selection of high-caliber authors.

Why of all things a book about benign prostate syndrome (BPS)? In a currently oncologically dominated urology, where immunotherapies, receptor blockers or the appropriate sequence therapy for prostate, bladder or renal cell carcinoma are discussed, BPS still represents THE operative backbone of every urological clinic, and this will remain so in the future due to an aging society.

Operative therapies of BPH have come and gone in the last 20 years on the graveyard of medical procedures! Nevertheless, the therapy of BPH is more than tamsulosin, monopolar TUR-P or open simple prostatectomy (OPS)! MTOPS or ComBAT trial have significantly influenced the medical therapy in the last 20 years. Laser ablation procedures with the holmium, thulium, or green light laser have emerged on the surgical horizon to stay permanently. In addition, the so-called Minimally-Invasive Surgical Therapies (MIST: iTind, Urolift, Rezum, Aquabeam, prostate artery embolization) for an individualized tailor-made therapy of BPH are on everyone’s lips. Whether these MIST therapies deliver what they promise remains to be seen.

A critical examination of the mentioned therapies can only succeed in a book with a certain time delay, as the elaborate production of a book always lags behind an original work or a review in terms of time. However, we see this time delay positively: The first “hype” about “new” and “complication-free” procedures is usually gone, critical publications that highlight the disadvantages of certain procedures also appear only with a time delay (or the flow of publications about a procedure dries up slowly). Therefore, a book succeeds much better in critically condensing what a urologist needs to know or what one can know than by skimming articles on various online portals of professional societies or publishers.

Finally, we are pleased that we were able to unite such high-caliber authors from the BPH and Endourology working groups of the German Society of Urology e. V. for the collaboration on this book.

We thank all the staff of Springer-Verlag in Berlin and thank them for their great help and uncomplicated cooperation, especially Ms. Ina Conrad, Ms. Susanne Sobich, Ms. Ellen Blasig and Mr. Amose Stanislaus. Springer-Verlag and all authors hope that this textbook will be a help and guidance for the urologist working in clinic and practice, provide pleasure in reading and above all serve the well-being of our patients.

Title: Benign Prostate Syndrome: Diagnostics and Therapy of the BPS

Author: Christopher Netsch, Andreas J. Gross

Publisher: Springer

Year: 2023

Edition: – Edition

Language: English

Pages: 257

Ebook: PDF

File size: 6 MB

ISBN Number: 3662670569, 9783662670569

CBID: CBM345